A novel effect of eicosapentaenoic acid: Improved diaphragm strength in endotoxemia

Critical Care

Volumn 14, Issue 2, 2010, Pages

  Calder, Philip C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; ENDOTOXIN; ICOSAPENTAENOIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BACTERIAL INFECTION; DIAPHRAGM; DRUG EFFECT; DRUG MECHANISM; ENDOTOXEMIA; ENZYME ACTIVATION; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; NOTE; PRIORITY JOURNAL; RAT; ANIMAL; PATHOPHYSIOLOGY;

ANIMALS; DIAPHRAGM; EICOSAPENTAENOIC ACID; ENDOTOXEMIA; MUSCLE STRENGTH;

EID: 78149267911     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8951     Document Type: Note

References (13)

1. Supinski GS, Vanags J, Callahan LA. Eicosapentaenoic acid preserves diaphragm force generation following endotoxin administration. Crit Care 2010, 14:R35. 10.1186/cc8913, 20233404.
2. Calder PC. Rationale and use of ω-3 fatty acids in artificial nutrition. Proc Nutr Soc 2010,
3. Saito M, Kubo K. Relationship between tissue lipid peroxidation and peroxidizability index after alpha-linolenic, eicosapentaenoic, or docosahexaenoic acid intake in rats. Br J Nutr 2003, 89:19-28. 10.1079/BJN2002731, 12568661.
4. Whitehouse AS, Tisdale MJ. Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation. Biochem Biophys Res Commun 2001, 285:598-602. 10.1006/bbrc.2001.5209, 11453634.
5. Khal J, Tisdale MJ. Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA). Biochem Biophys Res Commun 2008, 375:238-240. 10.1016/j.bbrc.2008.08.004, 18703014.
6. Magee P, Pearson S, Allen J. The omega-3 fatty acid, eicosapentaenoic acid (EPA), prevents the damaging effects of tumour necrosis factor (TNF)- alpha during murine skeletal muscle cell differentiation. Lipids Health Dis 2008, 7:24. 2500009, 18638380, 10.1186/1476-511X-7-24.
7. Calder PC. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83:1505S-1519S.
8. Calder PC. Use of fish oil in parenteral nutrition: rationale and reality. Proc Nutr Soc 2006, 65:264-277. 10.1079/PNS2006500, 16923311.
9. Barbosa VM, Miles EA, Calhau C, Lafuente E, Calder PC. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 2010, 14:R5. 10.1186/cc8844, 20085628.
10. Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, Van Hoozen C, Wennberg AK, Nelson JL, Noursalehi M. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999, 27:1409-1420. 10.1097/00003246-199908000-00001, 10470743.
11. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006, 34:1033-1038. 10.1097/01.CCM.0000206111.23629.0A, 16484911.
12. Pontes-Arruda A, Aragão AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006, 34:2325-2333. 10.1097/01.CCM.0000234033.65657.B6, 16850002.
13. Pacht ER, DeMichele SJ, Nelson JL, Hart J, Wennberg AK, Gadek JE. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med 2003, 31:491-500. 10.1097/01.CCM.0000049952.96496.3E, 12576957.